214 related articles for article (PubMed ID: 23442049)
1. Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cells.
Okamoto M; Chono H; Kawano Y; Saito N; Tsuda H; Inoue K; Kato I; Mineno J; Baba M
Hum Gene Ther Methods; 2013 Apr; 24(2):94-103. PubMed ID: 23442049
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of HIV-1 resistance in T lymphocytes using an ACA-specific E. coli mRNA interferase.
Chono H; Matsumoto K; Tsuda H; Saito N; Lee K; Kim S; Shibata H; Ageyama N; Terao K; Yasutomi Y; Mineno J; Kim S; Inouye M; Kato I
Hum Gene Ther; 2011 Jan; 22(1):35-43. PubMed ID: 20649483
[TBL] [Abstract][Full Text] [Related]
3. Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals.
Jacobson JM; Jadlowsky JK; Lacey SF; Fraietta JA; Plesa G; Chono H; Lee DH; Kulikovskaya I; Bartoszek C; Chen F; Tian L; Dimitri A; Levine BL; Veloso EA; Hwang WT; June CH
Mol Ther; 2021 Feb; 29(2):626-635. PubMed ID: 33186691
[TBL] [Abstract][Full Text] [Related]
4. Induction of E. coli-derived endonuclease MazF suppresses HIV-1 production and causes apoptosis in latently infected cells.
Okamoto M; Chono H; Hidaka A; Toyama M; Mineno J; Baba M
Biochem Biophys Res Commun; 2020 Sep; 530(3):597-602. PubMed ID: 32747090
[TBL] [Abstract][Full Text] [Related]
5. In vivo safety and persistence of endoribonuclease gene-transduced CD4+ T cells in cynomolgus macaques for HIV-1 gene therapy model.
Chono H; Saito N; Tsuda H; Shibata H; Ageyama N; Terao K; Yasutomi Y; Mineno J; Kato I
PLoS One; 2011; 6(8):e23585. PubMed ID: 21858176
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.
Poznansky MC; Foxall R; Mhashilkar A; Coker R; Jones S; Ramstedt U; Marasco W
Hum Gene Ther; 1998 Mar; 9(4):487-96. PubMed ID: 9525310
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells and monocytes derived from CD34+ cells transduced with an intracellular antibody directed against human immunodeficiency virus type 1 Tat.
Poznansky MC; La Vecchio J; Silva-Arietta S; Porter-Brooks J; Brody K; Olszak IT; Adams GB; Ramstedt U; Marasco WA; Scadden DT
Hum Gene Ther; 1999 Oct; 10(15):2505-14. PubMed ID: 10543615
[TBL] [Abstract][Full Text] [Related]
9. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.
Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA
Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371
[TBL] [Abstract][Full Text] [Related]
11. MazF-expressing T cells could suppress HIV replication.
Immunotherapy; 2011 Mar; 3(3):310. PubMed ID: 21520506
[No Abstract] [Full Text] [Related]
12. A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes.
Rustanti L; Jin H; Lor M; Lin MH; Rawle DJ; Harrich D
Virol J; 2017 Mar; 14(1):52. PubMed ID: 28288662
[TBL] [Abstract][Full Text] [Related]
13. Regression of solid tumors by induction of MazF, a bacterial mRNA endoribonuclease.
Shimazu T; Mirochnitchenko O; Phadtare S; Inouye M
J Mol Microbiol Biotechnol; 2014; 24(4):228-33. PubMed ID: 25196606
[TBL] [Abstract][Full Text] [Related]
14. Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication.
San José E; Muñoz-Fernández MA; Alarcón B
Hum Gene Ther; 1998 Jun; 9(9):1345-57. PubMed ID: 9650619
[TBL] [Abstract][Full Text] [Related]
15. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
[TBL] [Abstract][Full Text] [Related]
16. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
[TBL] [Abstract][Full Text] [Related]
17. Antitat gene therapy: a candidate for late-stage AIDS patients.
Lisziewicz J; Sun D; Lisziewicz A; Gallo RC
Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253
[TBL] [Abstract][Full Text] [Related]
18. Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA.
Mautino MR; Morgan RA
Hum Gene Ther; 2002 Jun; 13(9):1027-37. PubMed ID: 12067436
[TBL] [Abstract][Full Text] [Related]
19. Strong
Jin H; Sun Y; Li D; Lin MH; Lor M; Rustanti L; Harrich D
mBio; 2019 Aug; 10(4):. PubMed ID: 31455650
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes.
Ramezani A; Ding SF; Joshi S
Gene Ther; 1997 Aug; 4(8):861-7. PubMed ID: 9338016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
